InvestorsHub Logo
Followers 27
Posts 1397
Boards Moderated 0
Alias Born 07/31/2014

Re: stratford1 post# 34

Tuesday, 03/17/2015 11:42:36 AM

Tuesday, March 17, 2015 11:42:36 AM

Post# of 72
AXDX - Citron Research is run by Andrew Edward Left (born July 9, 1970 in Detroit Michigan) is an activist short seller, author and editor of the online investment newsletter Citron Research, formerly StockLemon.com...

This is a major attempt to discredit a very reputable bio venture management team that has taken over AXDX... there is absolutely nothing to the research provided by Citron Research... they have no biotechnology expertise to draw from... the recent SEC correspondence DID NOT shine any new light on the ID/AST technology underdevelopment... there has been no "exposure of fraud"... the technology works as described... and will be a "game changing" technology that will meet vast acceptance once clinical testing is complete and FDA approval is met...

The shareholder lawsuits but the ambulance chasing law firms... is only part of the SHORT selling strategy...

Despite all of this noise... AXDX continues to get significant government grant funding from NIH... and its collaborative partners include the prestigious Washington University School of Medicine in St. Louis...

This is a development stage biotechnology firm... there are little if any revenues... it is well capitalized... and well managed... the technology continues to demonstrate significant reduction in time of identification of multi-drug resistant bacteria... the technology has just received ISA 13485:2003 certifications on its initial installation... and continued expansion of its partner utilization network is occurring at present to gather more testing feedback on the device and technologies applications...

You might very well utilize this very well coordinated SHORT SCARE to find a great entry point for a company that will see PPS between $45 to $70 by mid to late 2016... when the product (which is a razor / razor blade product model)... is fully being marketed with a potential market of every hospital and micro/molecular laboratory in North America... then Europe... then Asia... then everywhere else...

GO AXDX!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AXDX News